Generic Name and Formulations:
Trimethoprim (as HCl) 50mg/5mL; bubble-gum flavored soln; alcohol- and dye-free.
Aytu BioScience, Inc.
Indications for PRIMSOL:
Susceptible acute otitis media (AOM) due to S. pneumoniae or H. influenzae in children. Susceptible initial episodes of uncomplicated UTIs in adults.
UTIs: 100mg twice daily, or 200mg once daily; both for 10 days. Renal dysfunction: CrCl 15–30mL/min: reduce dose by ½; CrCl <15mL/min: not recommended.
<6months: not recommended. ≥6months: AOM: 10mg/kg daily in 2 divided doses every 12 hours for 10 days. Renal dysfunction: CrCl 15–30mL/min: reduce dose by ½; CrCl <15mL/min: not recommended.
Megaloblastic anemia due to folate deficiency.
Avoid large doses or prolonged administration (increased risk of blood disorders). Monitor CBC, discontinue if signs of blood disorders occur. Possible folate deficiency (may give folate concomitantly). Renal or hepatic impairment. Pregnancy (Cat.C). Nursing mothers.
May potentiate phenytoin. May interfere with some creatinine tests (alkaline picrate reduction).
Folic acid inhibitor.
Rash, GI upset, hematological or renal effects.
Endocrinology Advisor Articles
- Use of In-Hospital Continuous Subcutaneous Insulin Infusion: A Consensus Statement
- Better Control With DPP-4 Inhibitors vs NPH Insulin in Type 2 Diabetes
- Achieving Glycemic Control in T2D After Basal Insulin Initiation
- Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up
- Effects of the Two Types of Anorexia Nervosa on Bone Metabolism
- Diabetes Treatments
- Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
- No Link Between HbA1c Levels and Wound Healing in Patients With Diabetic Foot Ulcers
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- Risk for Iodine Deficiency and Hypothyroidism High in Children on Parenteral Nutrition
- Inverse Association Between Serum 25(OH)D Levels and Risk for Diabetes
- Glycemic Control Variations for Children, Adolescents With T1D in High-Income Countries
- Late-Life Mobility Limitations Linked to Obesity After Arthroplasty for OA in Women
- Fracture Risk Should Be Monitored in Bisphosphonate Drug Holiday
- Provider Counseling for Weight Loss Up for Arthritis, Overweight